We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$2.52B
AUM Growth
+$249M
Cap. Flow
+$45.6M
Cap. Flow %
1.81%
Top 10 Hldgs %
28.16%
Holding
266
New
9
Increased
91
Reduced
111
Closed
9

Sector Composition

Rank Sector Weight
1 Financials 18.37%
2 Technology 17.39%
3 Healthcare 10.53%
4 Consumer Discretionary 8.32%
5 Consumer Staples 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHOP icon
101
Shopify
SHOP
$169B
$3.1M 0.12%
77,840
-1,200
-2% -$40.6K
UL icon
102
Unilever
UL
$144B
$3.1M 0.12%
48,115
-1,634
-3% -$109K
TWLO icon
103
Twilio
TWLO
$29.5B
$3M 0.12%
30,540
-845
-3% -$86.3K
CRM icon
104
Salesforce
CRM
$149B
$2.94M 0.12%
18,094
-312
-2% -$48.9K
IJH icon
105
iShares Core S&P Mid-Cap ETF
IJH
$123B
$2.67M 0.11%
64,740
+2,835
+5% +$112K
XLE icon
106
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
$2.62M 0.1%
87,114
+72,654
+502% +$2.15M
VWO icon
107
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$2.58M 0.1%
58,051
+10,132
+21% +$429K
IWF icon
108
iShares Russell 1000 Growth ETF
IWF
$119B
$2.51M 0.1%
56,972
-6,088
-10% -$254K
MIC
109
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$2.36M 0.09%
55,177
+9,650
+21% +$398K
INTC icon
110
Intel
INTC
$435B
$2.14M 0.08%
35,692
+16
+0% +$895
SPLV icon
111
Invesco S&P 500 Low Volatility ETF
SPLV
$7.28B
$1.86M 0.07%
31,923
+4,153
+15% +$238K
IBM icon
112
IBM
IBM
$214B
$1.81M 0.07%
14,114
-1,235
-8% -$161K
EEM icon
113
iShares MSCI Emerging Markets ETF
EEM
$28B
$1.77M 0.07%
39,384
-510
-1% -$21.9K
MS icon
114
Morgan Stanley
MS
$333B
$1.66M 0.07%
32,438
-300
-0.9% -$14.2K
KMB icon
115
Kimberly-Clark
KMB
$37.5B
$1.62M 0.06%
11,795
-100
-0.8% -$13.5K
USB icon
116
US Bancorp
USB
$100B
$1.42M 0.06%
24,010
AEP icon
117
American Electric Power
AEP
$72.4B
$1.4M 0.06%
14,859
+193
+1% +$17.8K
RARE icon
118
Ultragenyx Pharmaceutical
RARE
$2.56B
$1.4M 0.06%
32,708
-250
-0.8% -$10.3K
IJT icon
119
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.27B
$1.29M 0.05%
13,398
-1,050
-7% -$97K
IWM icon
120
iShares Russell 2000 ETF
IWM
$80.4B
$1.28M 0.05%
7,701
+290
+4% +$45.8K
WPC icon
121
W.P. Carey
WPC
$16.8B
$1.27M 0.05%
16,249
-77
-0.5% -$6.45K
VBK icon
122
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$1.27M 0.05%
6,400
+2,030
+46% +$385K
XBI icon
123
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$1.27M 0.05%
13,340
+350
+3% +$30.3K
PFE icon
124
Pfizer
PFE
$144B
$1.25M 0.05%
33,751
-27
-0.1% -$962
LQD icon
125
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.5B
$1.25M 0.05%
9,743
+6,240
+178% +$795K

Similar funds

Crestwood Advisors Group's Q4 2019 Portfolio in Review

As of Q4 2019, Crestwood Advisors Group held 266 positions worth $2.52B, up 11% from $2.27B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Crestwood Advisors Group's Q4 2019 filing shows 9 new, 91 increased, 111 reduced and 9 closed positions. Its largest new stake was Cue Biopharma: 9,000 shares worth $4.29M. The largest sale was EOG Resources, an estimated $2.94M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Crestwood Advisors Group's largest Q4 2019 buy was Cue Biopharma: 9,000 shares worth $4.29M.
  • Crestwood Advisors Group added most to iShares Core S&P Small-Cap ETF in Q4 2019, an estimated $13.7M increase.
  • Crestwood Advisors Group's biggest Q4 2019 reduction was EOG Resources, cutting an estimated $2.94M.
  • Crestwood Advisors Group fully exited Celgene Corp in Q4 2019, selling an estimated $720K.
  • Crestwood Advisors Group's ten largest holdings make up 28% of its $2.52B portfolio in Q4 2019.
  • Crestwood Advisors Group opened 9 new positions and closed 9 in Q4 2019.
  • Crestwood Advisors Group's portfolio value rose 11% quarter-over-quarter to $2.52B.

Based on Crestwood Advisors Group's 13F filing for Q4 2019, filed 12 Feb 2020.